Advances in molecular biology and tumor immunology have enabled the development of therapeutic fusion proteins, having the ability to activate immunologically cold microenvironments without the safety concerns associated with cytokine therapies


Roots Analysis has announced the addition of the “Immunocytokines Market, 2021-2030” report to its list of offerings.

These engineered pharmacologically-active molecules have, so far, demonstrated better efficacy and reduced toxicity compared to conventional cytokine-based therapies. As a result, immunocytokines are now being investigated for the treatment of a wide array of target indications, including cancers, autoimmune disorders, and certain chronic inflammatory diseases.

To order this 175+ page report, which features 95+ figures and 115+ tables, please visit

Leave a Reply

Your email address will not be published. Required fields are marked *